Tonix Launches Decisive Fibromyalgia Treatment Trial Plus Big Year for Fibromyalgia Drugs?
Tonix's TNX-102 SL drug for fibromyalgia has had a wild ride. Despite all the ups and downs the pain and sleep relieving drug is about to begin its decisive trial.
Looking Forward to 2022 Pt. II: Fibromyalgia and ME/CFS Clinical Trials Plus Six Potential Game-changers
Check out fibromyalgia and chronic fatigue syndrome clinical trials projected to end late last year or this year to see what 2022 may bring.
Still at the Beginning? The Hunt for Better Drugs for Fibromyalgia
The authors propose that a new approach to fibromyalgia is needed to produce better drug treatments. They focused on cannabinoids, NMDA receptors, neuroinflammatory drugs, etc.
Future Drugs for Fibromyalgia and Chronic Fatigue Syndrome (ME/CFS)? A Clinical Trials Survey
Not satisfied with how your treatments for fibromyalgia and/or chronic fatigue syndrome (ME/CFS) is going? Look to the future at the drugs trials underway in both these diseases as well as other trials in other diseases that may help.
Fibromyalgia Researcher & Doctor Asks “Chronic Pain: Is It All in Your Head” (Hint: It’s Not Psychological)
Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
